Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells

Journal of Clinical Investigation

Volumn 119, Issue 5, 2009, Pages 1264-1274

  Bao, Lihua ^a   Haas, Mark ^b   Pippin, Jeffrey ^c   Wang, Ying ^a   Miwa, Takashi ^d   Chang, Anthony ^a   Minto, Andrew W ^a   Petkova, Miglena ^a   Qiao, Guilin ^a   Song, Wen Chao ^d   Alpers, Charles E ^c   Zhang, Jian ^a   Shankland, Stuart J ^c   Quigg, Richard J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; IMMUNOGLOBULIN G; ANTIBODY; CD59A PROTEIN, MOUSE; DECAY ACCELERATING FACTOR 1, MOUSE; DECAY-ACCELERATING FACTOR 1, MOUSE;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL DAMAGE; CELL ULTRASTRUCTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; HISTOLOGY; INFLAMMATION; KIDNEY TRANSPLANTATION; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; WILD TYPE; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CELL MOTION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; GENETICS; GLOMERULUS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MONOCYTE; MOUSE MUTANT; NUDE MOUSE; PATHOLOGY; SHEEP; TRANSPLANTATION; URINE;

ALBUMINURIA; ANIMALS; ANTIBODIES; ANTIBODY FORMATION; ANTIGENS, CD55; ANTIGENS, CD59; CELL MOVEMENT; DISEASE MODELS, ANIMAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; MICE, SCID; MONOCYTES; PODOCYTES; SHEEP; T-LYMPHOCYTES;

EID: 66449095349     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI36000     Document Type: Article

References (57)

1. Walport, M.J. 2001. Advances in immunology: complement (first of two parts). N. Engl. J. Med. 344:1058-1066.
2. Speth, C., Prodinger, W.M., Würzner, R., Stoibert, H., and Dierich, M.P. 1993. Complement. In Fundamental immunology. 6th edition. W.E. Paul, editor. Lippincott Williams & Wilkins. Baltimore, Maryland, USA. 1047-1078.
3. Holers, V.M. 2001. Complement deficiencies. In Clinical immunology: principles and practice. 2nd edition. R. Rich, editor. Mosby. St. Louis, Missouri, USA. 36.1-36.10.
4. Harris, C.L., Rushmere, N.K., and Morgan, B.P. 1999. Molecular and functional analysis of mouse decay accelerating factor (CD55). Biochem. J. 341:821-829.
5. Lin, F., Emancipator, S.N., Salant, D.J., and Medof, M.E. 2002. Decay-accelerating factor confers protection against complement- mediated podocyte injury in acute nephrotoxic nephritis. Lab. Invest. 82:563-569.
6. Lin, F., et al. 2004. Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis. J. Immunol. 172:2636-2642.
7. Sogabe, H., et al. 2001. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis. J. Immunol. 167:2791-2797.
8. O'Brien, D.P., et al. 2006. The role of decay-accelerating factor as a receptor for Helicobacter pylori and a mediator of gastric inflammation. J. Biol. Chem. 281:13317-13323.
9. Davis, L.S., Patel, S.S., Atkinson, J.P., and Lipsky, P.E. 1988. Decay-accelerating factor functions as a signal transducing molecule for human T cells. J. Immunol. 141:2246-2252.
10. Shenoy-Scaria, A.M., et al. 1992. Signal transduction through decay-accelerating factor: Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1. J. Immunol. 149:3535-3541.
11. Hamann, J., Vogel, B., van Schijndel, G.M., and van Lier, R.A. 1996. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp. Med. 184:1185-1189.
12. Qian, Y.M., Haino, M., Kelly, K., and Song, W.C. 1999. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55). Immunology. 98:303-311.
13. Liu, J., et al. 2005. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J. Exp. Med. 201:567-577.
14. Heeger, P.S., et al. 2005. Decay-accelerating factor modulates induction of T cell immunity. J. Exp. Med. 201:1523-1530.
15. Shankland, S.J. 2006. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 69:2131-2147.
16. Savin, V.J., et al. 1996. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N. Engl. J Med. 334:878-883.
17. Quigg, R.J., et al. 1989. Studies with antibodies to cultured rat glomerular epithelial cells: Subepithelial immune deposit formation after in vivo injection. Am. J. Pathol. 134:1125-1133.
18. Lin, F., et al. 2001. Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology. 104:215-225.
19. Quigg, R.J., Nicholson-Weller, A., Cybulsky, A.V., Badalamenti, J., and Salant, D.J. 1989. Decay accelerating factor regulates complement activation on glomerular epithelial cells. J. Immunol. 142:877-882.
20. Huang, X.R., Holdsworth, S.R., and Tipping, P.G. 1997. Th2 responses induce humorally mediated injury in experimental anti-glomerular basement membrane glomerulonephritis. J. Am. Soc. Nephrol. 8:1101-1108.
21. Chen, J.S., et al. 2006. Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrol. Dial. Transplant. 19:2721-2728.
22. Soos, T.J., et al. 2006. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int. 70:591-596.
23. Ma, L.J., and Fogo, A.B. 2003. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int. 64:350-355.
24. Diamond, J.R., Bonventre, J.V., and Karnovsky, M.J. 1986. A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int. 29:478-483.
25. Kawaguchi, M., Yamada, M., Wada, H., and Okigaki, T. 1992. Roles of active oxygen species in glomerular epithelial cell injury in vitro caused by puromycin aminonucleoside. Toxicology. 72:329-340.
26. Qi, Z., et al. 2005. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes. 54:2628-2637.
27. He, C., et al. 1996. Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J. Clin. Invest. 97:1242-1249.
28. Huang, X.R., Tipping, P.G., Shuo, L., and Holdsworth, S.R. 1997. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int. 51:94-103.
29. Holdsworth, S.R., Kitching, A.R., and Tipping, P.G. 1999. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int. 55:1198-1216.
30. Ruggenenti, P., and Remuzzi, G. 2000. The role of protein traffic in the progression of renal diseases. Annu. Rev. Med. 51:315-327.
31. Meyer, T.N., et al. 2007. A new mouse model of immune-mediated podocyte injury. Kidney Int. 72:841-852.
32. Miwa, T., et al. 2001. Characterization of glycosylphosphatidylinositol- anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity. Immunology. 104:207-214.
33. Bao, L., et al. 2002. Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes. Kidney Int. 62:2010-2021.
34. Bao, L., Haas, M., Minto, A.W., and Quigg, R.J. 2007. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis. Lab. Invest. 87:357-364.
35. Yamada, K., Miwa, T., Liu, J., Nangaku, M., and Song, W.C. 2004. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J. Immunol. 172:3869-3875.
36. Pinto, J., et al. 1981. Recurrence of focal segmental glomerulosclerosis in renal allografts. Transplantation. 32:83-89.
37. Senggutuvan, P., et al. 1990. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr. Nephrol. 4:21-28.
38. Hubsch, H., et al. 2005. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience. Pediatr. Nephrol. 20:210-216.
39. Godfrin, Y., et al. 1997. Study of the in vitro effect on glomerular albumin permselectivity of serum before and after renal transplantation in focal segmental glomerulosclerosis. Transplantation. 64:1711-1715.
40. Neuhaus, T.J., Wadhwa, M., Callard, R., and Barratt, T.M. 1995. Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome. Clin. Exp. Immunol. 100:475-479.
41. Yap, H.K., et al. 1999. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J. Am. Soc. Nephrol. 10:529-537.
42. Liu, J., et al. 2008. IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J. Immunol. 180:5882-5889.
43. Strainic, M.G., et al. 2008. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity. 28:425-435.
44. Hume, D.A., Robinson, A.P., MacPherson, G.G., and Gordon, S. 1983. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J. Exp. Med. 158:1522-1536.
45. Kruger, T., et al. 2004. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J. Am. Soc. Nephrol. 15:613-621.
46. Woltman, A.M., et al. 2007. Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions. Kidney Int. 71:1001-1008.
47. Patole, P.S., et al. 2006. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol. Dial. Transplant. 21:3062-3073.
48. Masaki, T., Chow, F., Nikolic-Paterson, D.J., Atkins, R.C., and Tesch, G.H. 2003. Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis. Nephrol. Dial. Transplant. 18:178-181.
49. Yoo, K.H., et al. 2006. Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney Int. 70:1735-1741.
50. Kitagawa, K., et al. 2004. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am. J. Pathol. 165:237-246.
51. Dong, X., et al. 2007. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 71:619-628.
52. Miwa, T., Zhou, L., Hilliard, B., Molina, H., and Song, W.C. 2002. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood. 99:3707-3716.
53. Cunningham, P.N., Wang, Y., Guo, R., He, G., and Quigg, R.J. 2004. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J. Immunol. 172:2629-2635.
54. Yu, P., et al. 2004. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat. Immunol. 5:141-149.
55. Rabb, H., et al. 2000. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am. J. Physiol. Renal Physiol. 279:F525-F531.
56. Burne, M.J., et al. 2001. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J. Clin. Invest. 108:1283-1290.
57. Quigg, R.J., et al. 1998. Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int. 53:320-330.